ThermoGenesis (KOO) Enters Res-Q 60 Market Agreement with Arthrex
Tweet
Share
E-mailGet Alerts KOOL Hot Sheet
Join SI Premium – FREE
ThermoGenesis Corp. (NASDAQ: KOOL), has entered into a five year collaboration with Arthrex, Inc., under which Arthrex will market ThermoGenesis' Res-Q 60 (Res-Q) System technology for use in the preparation of autologous Platelet Rich Plasma (PRP) and Bone Marrow Concentrate (BMC).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aggreko files for proposed IPO
- Oppenheimer adds managing director, promotes municipal leader
- LPL Financial names Jonathan Lewis as chief technology officer
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
